publication venue for
- Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel.. 3. 2020
- PARP inhibitors: clinical development, emerging differences, and the current therapeutic issues. 2019